Treatment with n-3 Polyunsaturated Fatty Acids Overcomes the Inverse Association of Vitamin D Deficiency with Inflammation in Severely Obese Patients: A Randomized Controlled Trial

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Itariu, Bianca K ^a   Zeyda, Maximilian ^a   Leitner, Lukas ^a   Marculescu, Rodrig ^a   Stulnig, Thomas M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; OMEGA 3 ACID ETHYL ESTER;

ADULT; ARTICLE; BODY MASS; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; FATTY ACID BLOOD LEVEL; FEMALE; HEALTH STATUS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; OBESITY; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84872834289     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054634     Document Type: Article

References (33)

1. DeLuca HF, (2004) Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80: 1689S-1696S.
2. Kannus P, Uusi-Rasi K, Palvanen M, Parkkari J, (2005) Non-pharmacological means to prevent fractures among older adults. Ann Med 37: 303-310.
3. Verstuyf A, Carmeliet G, Bouillon R, Mathieu C, (2011) Vitamin D: a pleiotropic hormone. Kidney Int 78: 140-145.
4. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96: 1911-1930.
5. Carriere I, Delcourt C, Lacroux A, Gerber M, (2007) Nutrient intake in an elderly population in southern France (POLANUT): deficiency in some vitamins, minerals and omega-3 PUFA. Int J Vitam Nutr Res 77: 57-65.
6. Holick MF, (2007) Vitamin D deficiency. N Engl J Med 357: 266-281.
7. Pearce SH, Cheetham TD, (2010) Diagnosis and management of vitamin D deficiency. Bmj 340: b5664.
8. Bouillon R, van Baelen H, de Moor P, (1977) The measurement of the vitamin D-binding protein in human serum. J Clin Endocrinol Metab 45: 225-231.
9. Song X, Pitkaniemi J, Gao W, Heine RJ, Pyorala K, et al. (2011) Relationship between body mass index and mortality among Europeans. Eur J Clin Nutr 66: 156-165.
10. Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, et al. (2008) Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 28: 1039-1049.
11. Zeyda M, Stulnig TM, (2009) Obesity, inflammation, and insulin resistance-a mini-review. Gerontology 55: 379-386.
12. Forouhi NG, Ye Z, Rickard AP, Khaw KT, Luben R, et al. (2012) Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia 55: 2173-2182.
13. Hotamisligil GS, (2006) Inflammation and metabolic disorders. Nature 444: 860-867.
14. Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, et al. (2011) The global obesity pandemic: shaped by global drivers and local environments. Lancet 378: 804-814.
15. Mertens PR, Muller R, (2010) Vitamin D and cardiovascular risk. Int Urol Nephrol 42: 165-171.
16. Soni M, Kos K, Lang IA, Jones K, Melzer D, et al. (2012) Vitamin D and cognitive function. Scand J Clin Lab Invest Suppl 243: 79-82.
17. Holick MF, (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79: 362-371.
18. Naesgaard PA, Leon De La Fuente RA, Nilsen ST, Woie L, Aarsland T, et al. (2012) Serum 25(OH)D is a 2-year predictor of all-cause mortality, cardiac death and sudden cardiac death in chest pain patients from Northern Argentina. PLoS One 7: e43228.
19. Karakas M, Thorand B, Zierer A, Huth C, Meisinger C, et al. (2012) Low Levels of Serum 25-Hydroxyvitamin D Are Associated with Increased Risk of Myocardial Infarction, Especially in Women: Results from the MONICA/KORA Augsburg Case-Cohort Study. J Clin Endocrinol Metab Published online before print November 12, 2012, doi:10.1210/jc.2012-2368.
20. Calder PC, (2009) Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale. Biochimie 91: 791-795.
21. Itariu BK, Zeyda M, Hochbrugger EE, Neuhofer A, Prager G, et al. (2012) Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial. Am J Clin Nutr 96: 1137-1149.
22. Niramitmahapanya S, Harris SS, Dawson-Hughes B, (2011) Type of dietary fat is associated with the 25-hydroxyvitamin D3 increment in response to vitamin D supplementation. J Clin Endocrinol Metab 96: 3170-3174.
23. Vickers AJ, Altman DG, (2001) Statistics notes: Analysing controlled trials with baseline and follow up measurements. Bmj 323: 1123-1124.
24. Pitroda AP, Harris SS, Dawson-Hughes B, (2009) The association of adiposity with parathyroid hormone in healthy older adults. Endocrine 36: 218-223.
25. Grethen E, McClintock R, Gupta CE, Jones R, Cacucci BM, et al. (2011) Vitamin D and hyperparathyroidism in obesity. J Clin Endocrinol Metab 96: 1320-1326.
26. Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, et al. (2012) The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials 33: 159-171.
27. Andersen S, Laurberg P, Hvingel B, Kleinschmidt K, Heickendorff L, et al. (2012) Vitamin D status in Greenland is influenced by diet and ethnicity: a population-based survey in an Arctic society in transition. Br J Nutr Published online: 08 June 2012, doi:10.1017/S0007114512002097.
28. Rousseau JH, Kleppinger A, Kenny AM, (2009) Self-reported dietary intake of omega-3 fatty acids and association with bone and lower extremity function. J Am Geriatr Soc 57: 1781-1788.
29. Vieth R, (1999) Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69: 842-856.
30. Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR, (2011) 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 57: 63-69.
31. Bellia A, Garcovich C, D'Adamo M, Lombardo M, Tesauro M, et al. (2011) Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Intern Emerg Med Published online 25 March 2011, doi10.1007/s11739-011-0559-x.
32. Bakker GC, van Erk MJ, Pellis L, Wopereis S, Rubingh CM, et al. (2010) An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach. Am J Clin Nutr 91: 1044-1059.
33. Bouwens M, van de Rest O, Dellschaft N, Bromhaar MG, de Groot LC, et al. (2009) Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Am J Clin Nutr 90: 415-424.